# FDA Inspection 1171797 - Spark Therapeutics, Inc. - March 04, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/spark-therapeutics-inc/1a56c342-57f0-4c4d-be0b-3e75d182a188
Source feed: FDA_Inspections

> FDA Inspection 1171797 for Spark Therapeutics, Inc. on March 04, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171797
- Company Name: Spark Therapeutics, Inc.
- Inspection Date: 2022-03-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1289380 - 2025-10-30](https://www.globalkeysolutions.net/records/fda_inspections/spark-therapeutics-inc/fa196f80-255c-4098-853a-63f00b976ff7)
- [FDA Inspection 1171797 - 2022-03-04](https://www.globalkeysolutions.net/records/fda_inspections/spark-therapeutics-inc/ae7bc291-fbda-42c3-885c-6d8f574bf1c3)

Company: https://www.globalkeysolutions.net/companies/spark-therapeutics-inc/a5518493-a117-41d3-862d-96d5a5d3b6dd

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d